Express Pharma

Lupin’s subsidiary to set up plant in Japan


Kyowa Pharmaceutical Industry Co will set up the plant at Tottori, as part of expansion plans in the country

Lupin’s wholly-owned Japanese subsidiary, Kyowa Pharmaceutical Industry Co , plans to set up a manufacturing plant at Tottori, Japan as part of expansion plans in the country.

“In order to meet the rapidly growing demand of generics, the Kyowa board has proposed the setting-up of a two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion,” Lupin said in a regulatory filing.

Kyowa Pharmaceutical Industry Co, the wholly-owned subsidiary of the the Mumbai-based firm, has a manufacturing facility at Sanda, Japan. The drug maker, however, did not disclose financial details regarding the proposed plant.

Comments are closed.